[Current knowledge on the pathogenesis of common psoriasis as the basis for a scientifically founded therapy. II. Therapeutic possibilities and pathogenetic principles of antipsoriatic drugs].
D000873:Anthracenes / Q000627:therapeutic use; D001151:Arsenic / Q000627:therapeutic use; D001494:Baths; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008628:Mercury / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy* / Q000628:therapy; D012459:Salicylates / Q000627:therapeutic use*; D013638:Tars / Q000627:therapeutic use; D014467:Ultraviolet Therapy
D000873:Anthracenes; D005938:Glucocorticoids; D012459:Salicylates; D013638:Tars; D008628:Mercury; D001151:Arsenic; D008727:Methotrexate
Gegenwärtige Kenntnisse der Pathogenese der Psoriasis vulgaris als Grundlage einer wissenschaftlich begründeten Therapie. II. Therapeutische Möglichkeiten und pathogenetische Grundlagen der Antipsoriatika.